US 9951141
Antibody-drug conjugates, their preparation and their therapeutic use
granted A61KA61K2039/505A61K2039/507
Quick answer
US patent 9951141 (Antibody-drug conjugates, their preparation and their therapeutic use) held by REGENERON PHARMACEUTICALS, INC. expires Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- REGENERON PHARMACEUTICALS, INC.
- Grant date
- Tue Apr 24 2018 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Apr 19 2038 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 54
- CPC classes
- A61K, A61K2039/505, A61K2039/507, A61K47/6801, A61K47/68031